Granted Patent
B2
US 7,871,815 · App. 11/580,095 · Granted Jan 18, 2011
Rhamnose-inducible expression constructs and methods
Assignee:
Vaxiion Therapeutics, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Abstract
Disclosed herein is a rhamnose-inducible expression vector.
Claims (5)
1. A method of producing a protein, comprising:
cloning an open reading frame encoding a protein into the nucleic acid sequence of SEQ ID 151;
introducing the resulting nucleic acid sequence into a host cell; and
exposing the host cell to rhamnose, thereby inducing expression of the protein.
2. A nucleotide sequence comprising SEQ ID 151.
Assignments (2)
ORGANIZATION CONVERSION
Recorded Apr 30, 2015
From: VAXIION THERAPEUTICS, INC.
To: VAXIION THERAPEUTICS, LLC
Reel/Frame 035557/0644 →
SECURITY AGREEMENT
Recorded Mar 21, 2013
From: VAXIION THERAPEUTICS INC.
To: WESTERN STATES INVESTMENT COMPANY, LLC
Reel/Frame 030062/0774 →
Continuity (5)
Division
1015690200
· May 28, 2002
Provisional Application
6029356600
· May 24, 2001
Provisional Application
6035984300
· Feb 25, 2002